WHO ICTRP trial
Rosuvastatin Calcium Tablets Human Bioequivalence Study
ChiCTR2500109091 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500109091 |
|---|---|
| Public title | Rosuvastatin Calcium Tablets Human Bioequivalence Study |
| Scientific title | A Single-Dose, Randomized, Open-Label, Two-Preparation, Two-Sequence, Two-Period, Crossover Bioequivalence Study of Rosuvastatin Calcium Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions |
| Primary sponsor | People's Hospital of Deyang City |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | hyperlipoproteinemia |
| Interventions | Group B:Take the reference preparation before taking the test preparation under fasting conditions, the washing period is 7 days.;Group C:Take the test preparation before taking the reference preparation under postprandial conditions, the… |
| Registration date | Sep 11, 2025 |
| Target size | Group B:12;Group C:16;Group A:12;Group D:16 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: